← Back to Search

Novel Blood Drawing Apparatus for Plasma Donation

N/A
Waitlist Available
Led By Michael F Holick, MD, PhD
Research Sponsored by Boston University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
at least 18 y/o
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the time of blood analysis.
Awards & highlights

Study Summary

This trial is testing a new collection tube that could save time and cost by eliminating centrifugation steps that are currently required to obtain serum and plasma.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the time of blood analysis.
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the time of blood analysis. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of subjects with similar blood chemistry values for both blood drawing apparatuses

Trial Design

1Treatment groups
Experimental Treatment
Group I: Novel DeviceExperimental Treatment1 Intervention
Every Subject will be assigned to the same arm. This arm calls for blood to be drawn using an original blood drawing apparatus as well as using the novel blood drawing apparatus.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Novel Blood Drawing Apparatus
2016
N/A
~20

Find a Location

Who is running the clinical trial?

Boston UniversityLead Sponsor
454 Previous Clinical Trials
9,941,552 Total Patients Enrolled
Michael F Holick, MD, PhDPrincipal InvestigatorBoston University
1 Previous Clinical Trials
16 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025